|
1
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bookman MA, Brady MF, McGuire WP, Harper
PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De
Geest K, et al: Evaluation of new platinum-based treatment regimens
in advanced-stage ovarian cancer: A Phase III Trial of the
Gynecologic Cancer Intergroup. J Clin Oncol. 27:1419–1425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McMeekin DS, Tillmanns T, Chaudry T, Gold
M, Johnson G, Walker J and Mannel R: Timing isn't everything: An
analysis of when to start salvage chemotherapy in ovarian cancer.
Gynecol Oncol. 95:157–164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ilmer M, Vykoukal J, Boiles A Recio,
Coleman M and Alt E: Two sides of the same coin: Stem cells in
cancer and regenerative medicine. FASEB J. 28:2748–2761. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan JK and Lam PY: Human mesenchymal stem
cells and their paracrine factors for the treatment of brain
tumors. Cancer Gene Ther. 20:539–543. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dittmer J and Leyh B: Paracrine effects of
stem cells in wound healing and cancer progression (Review). Int J
Oncol. 44:1789–1798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma S, Xie N, Li W, Yuan B, Shi Y and Wang
Y: Immunobiology of mesenchymal stem cells. Cell Death Differ.
21:216–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghobadi F, Mehrabani D and Mehrabani G:
Regenerative potential of endometrial stem cells: A mini review.
World J Plast Surg. 4:3–8. 2015.PubMed/NCBI
|
|
10
|
Raja FA, Chopra N and Ledermann JA:
Optimal first-line treatment in ovarian cancer. Ann Oncol. 23 Suppl
10:x118–x127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weidle UH, Birzele F, Kollmorgen G and
Rueger R: Mechanisms and targets involved in dissemination of
ovarian cancer. Cancer Genomics Proteomics. 13:407–423. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baer PC: Adipose-derived mesenchymal
stromal/stem cells: An update on their phenotype in vivo and in
vitro. World J Stem Cells. 6:256–265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang BJ, Lee SH, Kweon OK and Cho JY:
Differentiation of canine adipose tissue-derived mesenchymal stem
cells towards endothelial progenitor cells. Am J Vet Res.
75:685–691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minteer DM, Marra KG and Rubin JP: Adipose
stem cells: Biology, safety, regulation, and regenerative
potential. Clin Plast Surg. 42:169–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arie AB, McNally L, Kapp DS and Teng NN:
The omentum and omentectomy in epithelial ovarian cancer: A
reappraisal: Part II-The role of omentectomy in the staging and
treatment of apparent early stage epithelial ovarian cancer.
Gynecol Oncol. 131:784–790. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ben Arie A, McNally L, Kapp DS and Teng
NN: The omentum and omentectomy in epithelial ovarian cancer: A
reappraisal. Part I-Omental function and history of omentectomy.
Gynecol Oncol. 131:780–783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chu Y, Tang H, Guo Y, Guo J, Huang B, Fang
F, Cai J and Wang Z: Adipose-derived mesenchymal stem cells promote
cell proliferation and invasion of epithelial ovarian cancer. Exp
Cell Res. 337:16–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xue Z, Wu X, Chen X, Liu Y, Wang X, Wu K,
Nie Y and Fan D: Mesenchymal stem cells promote epithelial to
mesenchymal transition and metastasis in gastric cancer though
paracrine cues and close physical contact. J Cell Biochem.
116:618–627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meads MB, Gatenby RA and Dalton WS:
Environment-mediated drug resistance: A major contributor to
minimal residual disease. Nat Rev Cancer. 9:665–674. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi S and Wu D: Bone marrow-derived
mesenchymal stem cells protect against cisplatin-induced acute
kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med.
32:1262–1272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y,
Zhang B, Wang M, Mao F, Yan Y, et al: Exosomes released by human
umbilical cord mesenchymal stem cells protect against
cisplatin-induced renal oxidative stress and apoptosis in vivo and
in vitro. Stem Cell Res Ther. 4:342013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guan J and Chen J: Mesenchymal stem cells
in the tumor microenvironment. Biomed Rep. 1:517–521. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Boeck A, Pauwels P, Hensen K, Rummens
JL, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems
G, et al: Bone marrow-derived mesenchymal stem cells promote
colorectal cancer progression through paracrine neuregulin 1/HER3
signalling. Gut. 62:550–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roodhart JM, Daenen LG, Stigter EC, Prins
HJ, Gerrits J, Houthuijzen JM, Gerritsen MG, Schipper HS, Backer
MJ, van Amersfoort M, et al: Mesenchymal stem cells induce
resistance to chemotherapy through the release of platinum-induced
fatty acids. Cancer Cell. 20:370–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei HJ, Zeng R, Lu JH, Lai WF, Chen WH,
Liu HY, Chang YT and Deng WP: Adipose-derived stem cells promote
tumor initiation and accelerate tumor growth by interleukin-6
production. Oncotarget. 6:7713–7726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu L, Wang X, Wang J, Liu D, Wang Y, Huang
Z and Tan H: Hypoxia-induced secretion of IL-10 from
adipose-derived mesenchymal stem cell promotes growth and cancer
stem cell properties of Burkitt lymphoma. Tumour Biol.
37:7835–7842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Burger H, Loos WJ, Eechoute K, Verweij J,
Mathijssen RH and Wiemer EA: Drug transporters of platinum-based
anticancer agents and their clinical significance. Drug Resist
Updat. 14:22–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
